Search database
Filter
3893
Text search: drug therapy
Featured
Language
Document type
2564
498
480
132
75
57
45
16
12
8
4
1
1
Countries
271
113
101
100
88
85
80
74
72
68
63
57
56
55
50
49
49
46
43
42
40
37
36
36
35
32
32
30
29
27
21
17
17
16
15
14
11
11
11
11
11
10
10
10
9
8
8
8
7
7
7
6
6
6
6
6
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
414
275
248
138
134
86
73
62
61
49
32
29
27
26
25
24
23
22
21
18
18
18
18
18
18
17
17
17
16
16
16
14
14
14
13
13
13
13
12
12
12
12
12
12
11
10
10
10
10
10
10
9
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1465
439
181
132
53
38
35
1
Toolboxes
631
471
391
157
125
122
104
100
66
45
43
38
38
30
22
22
15
13
12
10
9
6
3
 Add to my MEDBOX

Guideline for Adverse Drug Events Monitoring (Pharmacovigilance), Ethiopia

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2014) C1
3rd edition
 Download
  View PDF
 Add to my MEDBOX

Treatment of Patients with Drug Addiction and Tuberculosis: New Strategies for the Future Directions

I. D. Montoya National Institute on Drug Abuse (2017) C2
Accessed 2017
 Download
  View PDF
 Add to my MEDBOX

Operation manual for isoniazid preventive therapy

Government of India; Ministry of Healt; Family Welfare National AIDS Control Organization (2016) C2
June, 2016
 External Link
 Add to my MEDBOX

Isoniazid preventive therapy for tuberculosis in South Africa: An assessment of the local evidence base

R Wood, L-G. Bekker (2014) CC
Review S Afr Med J 2014;104(3):174-177. DOI: 10.7196/SAMJ.7968
 External Link
 Add to my MEDBOX

Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis

J. Ayieko, L. Abuogi, B. Simchowitz, et al. BMC Infectious Diseases (2014) CC
Research Article BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
 Download
  View PDF
 Add to my MEDBOX

ARTs Based Therapy for Survivors of Trauma and Abuse in Government and NGO-Run Children's Home for Girls in Delhi

Save the Children (2016) C1
This article identifies the three core defining characteristics of healing environments for children and young people who have been exposed to chronic adversity and trauma. A large body of evidence highlights the pervasive and devastating developmental impacts of such exposure but there is also emer ... more
 Download
  View PDF
 Add to my MEDBOX

Antiepileptic drug treatment after first unprovoked seizure

World Health Organization (2012) C_WHO
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
 Download
  View PDF
 Add to my MEDBOX

Helping someone with drug use problems

Mental Health First Aid (Australia) (2019) C2
Mental Health First Aid Guidelines Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Antiretroviral drug chart

NAM; AIDSMAP (2019) CC
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions. The previous edition of the drugs chart is also available to download in Russian.
 Download
  View PDF
 Add to my MEDBOX

Global overview of drug demand and supply - Latest trends, cross-cutting issues

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -2-
 Download
  View PDF
 Add to my MEDBOX

Women and drugs - Drug use, drug supply and their consequences

United Nations Office on Drugs and Crime (2018) C2
World Drug Report 2018 -5-
 Download
  View PDF
 Add to my MEDBOX

Management of drug withdrawal

World Health Organization (2012) C_WHO
Q2: What interventions are safe and effective for drug withdrawal (cannabis, amphetamines, cocaine, benzodiazepines, and inhalants)?
 Download
  View PDF
 Add to my MEDBOX

Serbia National Drug Report 2017

European Monitoring Centre for Drugs and Drug Addiction; Republic of Serbia Ministry of Health (2017) C2
 External Link
 Add to my MEDBOX

National Institute on Drug Abuse NIH Online Resources

National Institute of Mental Health NIH (2019) CC
 Download
  View PDF
 Add to my MEDBOX

Time to Act. Pragmatic and concrete actions for prevention of non-medical use of controlled substances, treatment of drug use disorders, social protection and health care for people affected

United Nations Office on Drug and Crime UNODC (2019) CC
UNGASS 2016 OUTCOME IMPLEMENTATION
 External Link
 Add to my MEDBOX

Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia

T. Tsertsvadze; N. Chkhartishvili; L. Sharvadze; et al. Hindawi Publishing Corporation AIDS Research and Treatment (2011) C2
Research Article Hindawi Publishing Corporation AIDS Research and Treatment Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
 Download
  View PDF
 Add to my MEDBOX

Uniting to Build HIV Prevention for Drug Users - The Georgian Harm Reduction Network

P. Case USAID; PEPFAR (U.S. President's Emergency Plan for AIDS Relief), AIDSTAR-One (2012) C2
AIDSTAR-One | CASE STUDY SERIES November 2012
 Download
  View PDF
 Add to my MEDBOX

World Drug Report 2019 Booklet 1 Executive summary / Policy implications

United Nations Office on Drug and Crime UNODOC (2022) C1
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its spe ... more
 Download
  View PDF
 Add to my MEDBOX

World Drug Report 2022 Booklet 2 Global Overview of Drug Demand and Supply

United Nations Office on Drug and Crime UNODC (2022) C1
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs. The first chapter of the booklet begins with the latest estimates of the number of people who use dru ... more
 Download
  View PDF
 Add to my MEDBOX

WHO/HIVRESNET HIV drug resistance - laboratory operational framework

World Health Organization WHO (2020) C_WHO
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping lab ... more
 External Link
 Add to my MEDBOX

Medication adherence to antiretroviral therapy among newly treated people living with HIV

Y. Yu; D. Luo; X. Chen; et al. BMC Public Health (2018) CC
Yu et al. BMC Public Health (2018) 18:825 https://doi.org/10.1186/s12889-018-5731-z Research Article
 External Link
 Add to my MEDBOX

Interventions to improve antiretroviral therapy adherence among adolescents in low- and middle-income countries: A systematic review of the literature

K. Ridgeway; L. S. Dull K. R. Murray; et al. PLOS ONE (2018) CC
Research Article PLOS ONE | https://doi.org/10.1371/journal.pone.0189770 January 2, 2018
 External Link
 Add to my MEDBOX

Implementing an isoniazid preventive therapy program for people living with HIV in Thailand

Danyuttapolchai, J., S. Kittimunkong, S. Nateniyom, et al. (2016) CC
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
 External Link
 Add to my MEDBOX

First Antiretroviral Therapy Changes in People Living with HIV in Senegal: Incidence, Causes and Predictive Factors

Diouf A., T. J. Youbong, F. L. Dieye et. al. Journal of AIDS & Clinical Research (2017) C2
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau ... more
 Add to my MEDBOX

Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010-2019)

World Health Organization WHO (2020) C_WHO
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o ... more
 Download
  View PDF
 Add to my MEDBOX

Clinic-based survey of acquired HIV drug residence

World Health Organization WHO (2021) C_WHO
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and a ... more
 Download
  View PDF
 Add to my MEDBOX

Guideline for Adverse Drug Reactions Reporting for Healthcare Professionals

SAHPRA (2020) CC
Communication to Healthcare Professionals Mar-2020 This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o ... more
 Download
  View PDF
 Add to my MEDBOX

WHO Drug Information - Volume 36, No. 4

World Health Organisation (WHO) (2023) C_WHO
Pharmaceutical News Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis Consultation Documents Lamivudine and tenofovir disoproxil fumarate tablets (lami ... more
 Add to my MEDBOX

Therapy of Type 1 Diabetes

Haak, T.; Gölz, S.; Fritsche, A.; et al. German Diabetes Association (DDG) (2022) CC2
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured ... more
 Download
  View PDF
 Add to my MEDBOX

HIV and TB in Practice for nurses: Drug-resistant TB

Lesley Odendal (2013) CC
HIV & AIDS Treatment in Practice No.202
 Download
  View PDF
 Add to my MEDBOX

National Guidelines for the Use of Antiretroviral Therapy in Adults and Adolescents

National Center for HIVAIDS, Dermatology and STD, Cambodia Ministry of Health (2012) CC
 Add to my MEDBOX

Guidelines for the Management of Drug Resistant Tuberculosis in Kenya

Ministry of Public Health and Sanitation, Kenya (2010) CC
 Download
  View PDF
 Add to my MEDBOX

Anti-Malarial Drug Resistance in Cameroon

The Cameroon Academy of Sciences (2013) CC
 Download
  View PDF
 Add to my MEDBOX

Liberia National Drug Policy 2001

Ministry of Health and Social Welfare, Liberia (2010) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Management of Adverse Drug Effects of Antimycobacterial Agents

Lawrence Flick Memorial Tuberculosis Clinic, Philadelphia Tuberculosis Control Program (1998) C2
 Download
  View PDF
 Add to my MEDBOX

When to discontinue antiepileptic drug treatment in adults and children

World Health Organization WHO (2012) C_WHO
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
 External Link
 Add to my MEDBOX

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial

A. Turkova; C. L. Moore; K. Butler; et al. PLOS One; Pub Med (2018) CC
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
 Download
  View PDF
 Add to my MEDBOX

Guidance for sampling art clinics in countries combing surveillance of Pre-Treatment HIV drug resistance and acquired HIV drug resistance at 12 and 48+ months

World Health Organization (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

WHO recommendations on drug treatment for non-severe hypertension in pregnancy
recommended

World Health Organization WHO (2020) C_WHO
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi ... more
 External Link
 Add to my MEDBOX

Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide

World Health Organization WHO; Institutional research information sharing iris (2013) C_WHO
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
 Download
  View PDF
 Add to my MEDBOX

Preventing and responding to HIV drug resistance in the african region

World Health Organization WHO (Africa) World Health Organization WHO (Africa) (2019) C_WHO
Regional action plan 2019-2023
 Download
  View PDF
 Add to my MEDBOX

Chronic HIV Care with ARV Therapy and Prevention

World Health Organization (2007) C_WHO
Integrated Management of Adolescent and Adult Illness Integrated Management of Childhood Illness Interim Guidelines for health workers at health centre or district hospital outpatient clinic
 Download
  View PDF
 Add to my MEDBOX

Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach

World Health Organization WHO (2012) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Clinical Guidelines for Antiretroviral Therapy Management for Displaced Populations Southern Africa
recommended

Southern African HIV Clinicians Society UNHCR (2007)
 Add to my MEDBOX

Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis

José A. Caminero International Union Against Tuberculosis and Lung Disease (The Union) (2013)
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India + Annexures

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare (2012) C1
 Download
  View PDF
 Add to my MEDBOX

Family Planning–Integrated Antiretroviral Therapy: A Curriculum

EngenderHealthThe ACQUIRE Project (2008)
Trainer’s Manual
 Download
  View PDF
 Add to my MEDBOX

Community-Based Care for Drug-Resistant Tuberculosis: A Guide for Implementers

United States Agency for International Development (USAID) (2011)
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio ... more
 External Link
 Add to my MEDBOX

Operational Guidelines for the Management of Drug Resistant TB in Tanzania
recommended

Ministry of Health and Social Welfare, The United Republic of Tanzania (2012) C1
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
 Download
  View PDF
 Add to my MEDBOX

National Strategic Plan: Multi-Drug ARV for Prevention of Parent to Child Transmission of HIV (PPTCT) under National AIDS Control Programme in India

NACO (2013) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan (2012) CC
Revised National Tuberculosis Control Programme
 Download
  View PDF
 Add to my MEDBOX

Namibia: National Guidelines for Antiretroviral Therapy Fourth Edition
recommended

Ministry of Health and Social Services (MOHSS) (2014) C1
 Download
  View PDF
 Add to my MEDBOX

Programmatic Management of Drug Resistant Tuberculosis (PMDT)- Kenya
recommended

National Tuberculosis, Leprosy and Lung Disease Unit, Ministry of Health, Kenya (2014) C1
3rd edition
 Download
  View PDF
 Add to my MEDBOX

Double Trouble: Injection Drug Use and Sexual Behaviour

Bhattacharya A, et al. India HIVAIDS Alliance; Hridaya Harm Reduction in India (2015) C1
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P ... more
 Download
  View PDF
 Add to my MEDBOX

First Bangladesh National Tuberculosis Drug Resistance Survey 2010-2011

Ministry of Health and Family Welfare, Directorate-General of Health Services, Mycobacterial Disease Control, National Tuberculosis Control Programme (2013) C_WHO
 Download
  View PDF
 Add to my MEDBOX

India: OPERATIONAL MANUAL FOR ISONIAZID PREVENTIVE THERAPY

Central TB Division, Ministry of Health and Family Welfare, Government of India; NACO (2016) C1
 Download
  View PDF
 Add to my MEDBOX

National Guidelines for Antiretroviral Therapy, 5th ed.

Ministry of Health and Social Services (MOHSS) (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended

World Health Organization WHO (2017) C_WHO
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an ... more
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES ON DRUG REGISTRATION APPLICATIONS IN BOTSWANA, 4th edition

Ministry of Health, Gabarone, Botswana (2014)
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR DETECTING AND REPORTING ADVERSE DRUG OR VACCINE REACTIONS AND EVENTS IN ZAMBIA

Zambia Medicines Regulatory Authority (ZAMRA) (2006) C2
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
 Download
  View PDF
 Add to my MEDBOX

Guidelines for initiating a school-based directly observed therapy program

New Jersey Medical School; National Tuberculosis Center (2017) C1
Accessed November 2017.
 Download
  View PDF
 Add to my MEDBOX

Lesotho: NATIONAL GUIDELINES ON THE USE OF ANTIRETROVIRAL THERAPY FOR HIV PREVENTION AND TREATMENT

Ministry of Health, Government of Lesotho (2016) C2
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
 External Link
 Add to my MEDBOX

Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point

Y. Tadesse, N. Gebre, S. Daba, et al. PLOS One (2016) CC
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
 Download
  View PDF
 Add to my MEDBOX

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation

I. A. Vasilyeva Russian Ministry of Health (2017) C1
Accessed November 2017
 Download
  View PDF
 Add to my MEDBOX

Expansion Plan of Programmatic Management of Drug Resistant TB (PMDT)

National TB Control Programme, Bangladesh World Health Organization WHO, Bangladesh (2013) C1
 Download
  View PDF
 Add to my MEDBOX

Bosnia and Herzegovina - National Drug Situation Report 2017

European Monitoring Centre for Drugs and Drug Addiction (2018) C2
 Download
  View PDF
 Add to my MEDBOX

International Standards of Drug Use Prevention

World Health Organization (WHO); United Nations Office on Drug and Crime UNODC (2019) C_WHO
2nd revised edition. Accessed Apri. 17, 2019 Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ... more
 Download
  View PDF
 Add to my MEDBOX

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1
 Download
  View PDF
 Add to my MEDBOX

FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis

TB Alliance (2019) CC
 Download
  View PDF
 Add to my MEDBOX

The impact of drug policy on health and human rights in Eastern Europe

M. Hoekstra Eurasian Harm Reduction Network (2009) C2
10 years after the UN general assembly special session on drugs
 Download
  View PDF
 Add to my MEDBOX

HIV Programme Review in Albania: Antiretroviral therapy and procurement and supply management

J. V. Lazarus; M. Gottfredsson; N. Tavagnutti World Health Organization (Europe); Centre for Health & Infectious Disease Research (2015) C_WHO
March 2015
 Download
  View PDF
 Add to my MEDBOX

Key considerations for differentiated antiretroviral therapy delivery for specific populations: Children, adolescents, pregnant and breastfeeding women and key populations

World Health Organization; (CDC) Center for disease control and prevention; USAID; et al. (2017) C_WHO
 External Link
 Add to my MEDBOX

Barriers and facilitators to antiretroviral therapy adherence among Peruvian adolescents living with HIV: A qualitative study

J. T. Galea; M. Wong; M. Muñoz; et al. PLOS ONE; PMC (2018) CC
Research Article PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
 Download
  View PDF
 Add to my MEDBOX

Advocacy Guide: HIV/AIDS Prevention among injecting drug users

A. Ball; M. Beg; G. Weiler; et al. World Health Organization; UNAIDS; United Nations on Drugs and Crime (2004) C_WHO
 External Link
 Add to my MEDBOX

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon

G. F. Tchouwa; , S. Eymard-Duvernay; A. Cournil; et al. Elsevier; E Clinical Medecine (Published by the Lancet) (2018) C2
EClinicalMedicine 1 (2018) 21–27 https://doi.org/10.1016/j.eclinm.2018.06.005 2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). EClinicalMedicine: journal homepage: https://www.jo ... more
 Download
  View PDF
 Add to my MEDBOX

Differentiated care for HIV: A decision Framework for antiretroviral therapy delivery

Differentiated service delivery (2019) C2
It's time to deliver differently. Accessed: 13.11.2019
 Download
  View PDF
 Add to my MEDBOX

Pre Exposure Prophylaxis (PrEP) and HIV Drug Resistance

Global Evaluation of Microbicide Sensitivity GEMS (2017) C2
Training materials for healthcare workers
 Download
  View PDF
 Add to my MEDBOX

Guideline: Adherence to antiretroviral therapy in adolescents and young adults (expanded version)

L. Fairlie; L. Jankelowitz; H. Ronald; et al. Southern African HIV Clinicians Society; Right to Care (Training Health Seriously) (2017) C2
Recommendations, resources and references A publication of the Southern African HIV Clinicians Society
 Download
  View PDF
 Add to my MEDBOX

BHIVA treatment guidelines:interim statement on two-drug regimens

Waters, L. (2019) CC
 External Link
 Add to my MEDBOX

Beyond “Option B+”: Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa

L. Myer; T. K. Phillips J Acquir Immune Defic Syndr; World Health Organization (2017) C2
Supplement Article J Acquir Immune Defic Syndr  Volume 75, Supplement 2, June 1, 2017 www.jaids.com
 Download
  View PDF
 Add to my MEDBOX

Vietnam: National Action Plan on Combating Drug Resistance in the period from 2013 - 2020

Ministry of Health Vietnam (2013) C2
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of ... more
 Add to my MEDBOX

Considerations for introducing new antiretroviral drug formulations for children

World Health Organization WHO (2020) CC
Policy brief. July 2020
 Add to my MEDBOX

Nursing Guide for Managing Side Effectsto Drug-resistant TB Treatment

Raftery A, Tudor C, True L, Navarro C (2018) C1
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines on programmatic management of drug resistant tuberculosis in Ethiopia
recommended

Ministry of Health Ethiopia (2014) CC
2nd edition
 Download
  View PDF
 Add to my MEDBOX

TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis

International Council of Nurses (2015) C2
3rd edition.
 Download
  View PDF
 Add to my MEDBOX

The role of psychosocial interventions in drug treatment

European Monitoring Centre for Drugs and Drug Addiction (2016) C2
Perspectives on drugs
 Download
  View PDF
 Add to my MEDBOX

Zambia: Guidelines for the programmatic Management of Drug-Resistant Tuberculosis

National TBLeprosy Control Programme, Ministry of Health, Zambia (2013) C1
 Download
  View PDF
 Add to my MEDBOX

The Integrated National Guidelines on Antiretroviral Therapy Prevention of Mother to Child Transmission of HIV Infant & Young Child Feeding

Ministry of Health Uganda (2012) C1
1st edition
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 up-date

H. Schünemann, S.T. Aung, F. Bonsu et al. World Health Organisation (WHO) (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Integrated Biological and Behavioral Surveillance (IBBS) Survey among Female Injecting Drug Users in Kathmandu Valley, Round I, 2016

Ministry of Health Nepal; National Centre for AIDS and STD Control (NCASC) (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Roadmap to prevent and combat drug-resistant tuberculosis

World Health Organization Europe (2011) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Global action plan on HIV drug resistance 2017–2021

World Health Organization (WHO) (2017) C_WHO
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ... more
 Download
  View PDF
 Add to my MEDBOX

International Standards for the Treatment of Drug Use Disorders
recommended

World Health Organization, United Nations Office on Drugs and Crime (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe

A. T. Makadzange; M. Higgins-Biddle; B. Chimukangara; et al. PLOS One (2015) CC
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
 External Link
 Add to my MEDBOX

The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis

P. J. Dodd; A. J. Prendergas; C. Beecroft; et al. BMJ Journals (2017) CC
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
 Download
  View PDF
 Add to my MEDBOX

The Public Health Dimension of the World Drug problem

World Health Organization WHO (2019) C_WHO
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the use of delamanid in the treatment of drug-resistant TB in India
recommended

Ministry of Health & Family Welfare, India; World Health Organization (WHO) (2018) C1
 Download
  View PDF
 Add to my MEDBOX

Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis
recommended

World Health Organization WHO (2022) C_WHO
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB. This Ra ... more
 Add to my MEDBOX

Assessment of HIV testing services and antiretroviral therapy service disruptions in the context of COVID-19: lessons learned and way forward in sub-Saharan Africa

Maman, D.; et al., World Health Organization WHO (2021) CC
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic ... more
 Download
  View PDF
 Add to my MEDBOX

Effect of Perceived Social Support, Depression Symptoms, and Stigma on Adherence and Treatment Outcome of Highly Active Antiretroviral Therapy at Zewditu Memorial Hospital, Addis Ababa, Ethiopia

Alemu Tilahun, H. (2012) C1
Dissertation